QC
BIO icon

Quantedge Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantedge Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Sell
6,940
-7,200
-51% -$2.07M 1.06% 22
2025
Q4 		$4.28M Sell
14,140
-11,660
-45% -$3.64M 2.04% 14
2025
Q3 		$7.23M Buy
+25,800
New +$7.02M 3.96% 6

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantedge Capital's BIO Position: Q1 2026 in Review

Quantedge Capital reduced its Bio-Rad Laboratories Class A (BIO) stake by 51% in Q1 2026, selling an estimated $2.07M and leaving 6,940 shares worth $1.93M. The position accounts for 1.06% of the portfolio, ranked #22.

Quantedge Capital first reported a position in BIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.23M in Q3 2025. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Quantedge Capital held 6,940 shares of Bio-Rad Laboratories Class A worth $1.93M as of Q1 2026.
  • Quantedge Capital sold 7,200 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $2.07M.
  • Bio-Rad Laboratories Class A made up 1.06% of Quantedge Capital's portfolio in Q1 2026, its #22 holding.
  • Quantedge Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 3 quarters since.
  • Quantedge Capital's Bio-Rad Laboratories Class A position peaked at $7.23M in Q3 2025.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Quantedge Capital's 13F filing for Q1 2026, filed 12 May 2026.